M33 Growth
SlowingFiled to raiseBoston, MAHealthcare, Healthcare ServicesLast fund filed 2025
0 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Wellington Late-Stage Growth Partners VFiled to raise in 2025, with no closing reported yet. | 2025 | Indefinite | $0 | 0 |
| Wellington Growth Lending Opportunities Fund I | December 2024 | Indefinite | $36M | 65 |
| M33 Growth III | December 2022 | $340M | $340M | 47 |
| Putnam Catholic Values U.S. Large Cap Growth Fund | August 2022 | Indefinite | $36M | 9 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
3 partners are named across this firm’s filings, 0 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Gabriel LingNot on the current fund | Slowing | None listed | 3 |
Classified sectors of M33 Growth’s own portfolio companies, based on 3 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of M33 Growth’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
No other firm shares a filed board seat with M33 Growth yet. That is a gap in what we have read, not a claim that M33 Growth invests alone.
A shared board seat: a company where filings name a M33 Growth partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.
| February 2020 |
| $260M |
| $260M |
| 33 |
| Romulus EquipmentShare Growth IIFiled to raise in 2020, with no closing reported yet. | 2020 | Indefinite | $0 | 0 |
| Romulus EquipmentShare Growth IIIFiled to raise in 2020, with no closing reported yet. | 2020 | Indefinite | $0 | 0 |
| CWM PRIVATE EQUITY GROWTH FUND | October 2019 | $6M | $6M | 15 |
| Romulus Growth HumanyzeFiled to raise in 2018, with no closing reported yet. | 2018 | Indefinite | $0 | 0 |
| Romulus Growth Cogito IIFiled to raise in 2018, with no closing reported yet. | 2018 | Indefinite | $0 | 0 |
| M33 Growth I | October 2017 | $180M | $180M | 37 |
| Wellington Compound Growth | March 2017 | Indefinite | $266M | 30 |
| BPEA Small Buyout & Growth Fund I | February 2011 | Indefinite | $37M | 20 |
| Defensive Growth Emerging Markets Fund, a series of The PanAgora Group Trust | February 2006 | Indefinite | $166M | 6 |
| Wellington Growth Equity Long/Short Fund | 1997 | Indefinite | $654M | 183 |
| 1 |
| Brian ShortsleeveNot on the current fund | Quiet | None listed | 0 | 0 |
| Michael AnelloNot on the current fund | Quiet | None listed | 0 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.